Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 1GENZYME EUROPE B.V.
02 1Genzyme Europe B.V.
03 2Sanofi Bv
04 1Sanofi-Aventis (Switzerland) Sa
05 1Accord Healthcare S.L.U.
06 2Accord Healthcare Slu
07 1Eugia Pharma (Malta) Limited
08 1Glenmark Arzneimittel Gmbh
09 1Orifarm AS
10 2Seacross Pharma (Europe) Limited
11 1Seacross Pharma (Europe) Ltd.
12 1Stada Sl Laboratory
13 1Tarbis Farma Sl
14 1Teva Gmbh
15 1Tillomed Spain Laboratories Sl
16 1Viatris Limited
17 1Vivanta Generics Sro
Reset all filters
01 3Jm 3100
02 1Many People
03 2Pleriksafor
04 14Plerixafor
Reset all filters
01 15Injectable Solution
02 2Injection fluid, resolution
03 1Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
04 2Solution for injection
Reset all filters
01 1Italy
02 4Norway
03 8Spain
04 6Sweden
05 1Switzerland
Reset all filters
01 6Mozobil
02 1Plerazafor Accord
03 2Plerixafor Accord
04 1Plerixafor Eugia
05 1Plerixafor Glenmark
06 3Plerixafor Seacross
07 1Plerixafor Stada
08 1Plerixafor Tarbis
09 1Plerixafor Teva
10 1Plerixafor Tillomed
11 1Plerixafor Viatris
12 1Plerixafor Vivanta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Mozobil
Dosage Form : Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use
Dosage Strength : 1 bottle SC 24 mg 20 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Mozobil
Dosage Form : Injection fluid, resolution
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 15/08/2014
Application Number : 63139
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 31/07/2009
Application Number : 20080608000019
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Mozobil
Dosage Form : Injectable Solution
Dosage Strength : 20MG
Packaging :
Approval Date : 2009-11-12
Application Number : 09537001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : Norway
Brand Name : Plerixafor Accord
Dosage Form : Solution for injection
Dosage Strength : 20 mg/ml
Packaging : Vials 1 1.2ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Plerixafor Accord
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 16/12/2022
Application Number : 20211012000016
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Mozobil
Dosage Form : Injection fluid, resolution
Dosage Strength : 20 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Plerixafor Seacross
Dosage Form : Solution for injection
Dosage Strength : 20 mg/ml
Packaging : Vials 1 1.2ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Plerixafor Seacross
Dosage Form : Injectable Solution
Dosage Strength : 20mg/ml
Packaging :
Approval Date : 25/04/2023
Application Number : 20210809000017
Regulatory Info : Approved
Registration Country : Sweden